Alberto Ramírez

Activating Transcription Factor 4 Modulates TGFβ-Induced Aggressiveness in Triple-Negative Breast Cancer via SMAD2/3/4 and mTORC2 Signaling

Adrián González-González, Esperanza Muñoz‐Muela, Juan Antonio Marchal et al. · Clinical Cancer Research · 2018 · 64 citations · Full text

Medicine, Cancer Biology, Oncology +17

Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines

Ana Conejo‐García, María Eugenia García-Rubiño, Juan Antonio Marchal et al. · European Journal of Medicinal Chemistry · 2011 · 45 citations

Pharmacy, Medicinal Chemistry, Oncology +11

New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine

Ana Conejo‐García, Juan Antonio Marchal, Giuseppe Macchione et al. · European Journal of Medicinal Chemistry · 2010 · 45 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile

Gema Jiménez, Michael Hackenberg, Purificación Catalina et al. · Cancer Letters · 2018 · 41 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Albumin-covered lipid nanocapsules exhibit enhanced uptake performance by breast-tumor cells

F. Galisteo‐González, J. A. Molina‐Bolívar, Saúl A. Navarro-Marchal et al. · Colloids and Surfaces B Biointerfaces · 2018 · 31 citations · Full text

Pharmacy, Oncology, Pharmaceutics +16